CVS wants payback from GMP violators; Genzyme sued for Fabrazyme rationing;

> CVS Pharmacy is demanding $100 million from KV Pharmaceutical, Ethex and Nesher Pharmaceuticals for halting the supply of generics in 2008 due to GMP failures. News

> Fabry disease sufferers have filed suit against Genzyme and Mt. Sinai Medical School, the developer and license holder of Fabrazyme, for their handling of the drug shortage. Story

> Regional drug-production hubs created via big pharma tech transfer can improve public health and drive economic development in low- to mid-income countries, says Eli Lilly. Article

> Sanofi has recalled nearly 200,000 doses of the ActHIB flu vaccine in Japan; users found foreign matter in the syringes after injection. Story

> Amgen will buy a Pfizer manufacturing plant at Dun Laoghaire, County Dublin, securing 280 jobs. Release

> In response to a new healthcare reform reimbursement policy, doctors are balking at writing prescriptions for OTC products and pharmacists are complaining about filling them. Item

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.